ENDRA Life Sciences Inc.
NDRA- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- SEC CIK
- 0001681682
No open-market purchases or sales by ENDRA Life Sciences Inc. insiders were filed in the last 90 days; 10 institutions reported holding it in 13F filings for Q2 2026, worth $819.0K in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in ENDRA Life Sciences Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 20
- 0 vs. Q3 2021
- Shares held
- 4.42M
- +921.8K (+26.3%) vs. Q3 2021
- Total value
- $3.06M
- −$3.00M (−49.5%) vs. Q3 2021
- New holders
- 5
- 4 more added
- Sold out
- 5
- 3 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NDRA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 10 | $819.0K |
| Q1 2026 | 8 | $416.8K |
| Q4 2025 | 7 | $325.4K |
| Q3 2025 | 5 | $70.4K |
| Q2 2025 | 3 | $16.6K |
| Q1 2025 | 2 | $4.65K |
| Q4 2024 | 4 | $720 |
| Q3 2024 | 11 | $32.9K |
| Q2 2024 | 17 | $80.6K |
| Q1 2024 | 13 | $153.0K |
| Q4 2023 | 11 | $277.3K |
| Q3 2023 | 10 | $156.3K |
| Q2 2023 | 12 | $267.5K |
| Q1 2023 | 14 | $384.7K |
| Q4 2022 | 14 | $569.5K |
| Q3 2022 | 16 | $1.08M |
| Q2 2022 | 20 | $1.02M |
| Q1 2022 | 20 | $1.54M |
| Q4 2021 | 20 | $3.06M |
| Q3 2021 | 20 | $6.06M |
| Q2 2021 | 23 | $7.75M |
| Q1 2021 | 22 | $8.35M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding ENDRA Life Sciences Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bank of America Corp | 49 | $0 | 0.00% | +49 | New |
| Wells Fargo & Company | 1,306 | $1.00K | 0.00% | +1+0.1% | Added |
| Geneos Wealth Management Inc. | 1,500 | $1.00K | 0.00% | 00.0% | Unchanged |
| National Bank of Canada | 2,000 | $1.00K | 0.00% | +2,000 | New |
| Royal Bank of Canada | 15,310 | $11.0K | 0.00% | 00.0% | Unchanged |
| Ieq Capital, LLC | 17,111 | $12.0K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 28,200 | $19.0K | 0.00% | −80.0% | Reduced |
| Advisor Group Holdings, Inc. | 44,037 | $30.0K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 49,508 | $34.0K | 0.00% | +34,244+224.3% | Added |
| Northern Trust Corp | 63,378 | $44.0K | 0.00% | 00.0% | Unchanged |
| Raymond James & Associates | 70,854 | $49.0K | 0.00% | +70,854 | New |
| Virtu Financial LLC | 72,381 | $50.0K | 0.01% | +72,381 | New |
| 55I, LLC | 88,850 | $61.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 96,500 | $67.0K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 108,609 | $75.0K | 0.00% | +4,807+4.6% | Added |
| Renaissance Technologies LLC | 217,080 | $150.0K | 0.00% | +217,080 | New |
| Geode Capital Management, LLC | 323,679 | $223.0K | 0.00% | 00.0% | Unchanged |
| GWM Advisors LLC | 667,697 | $462.0K | 0.01% | −37,650−5.3% | Reduced |
| Morgan Stanley | 843,574 | $583.0K | 0.00% | +611,262+263.1% | Added |
| Vanguard Group Inc | 1,711,771 | $1.18M | 0.00% | −2,057−0.1% | Reduced |
| Blair William & Co | 0 | $0 | 0.00% | −35,000−100.0% | Sold out |
| Spire Wealth Management | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Massmutual Trust Co FSB | 0 | $0 | 0.00% | −5,910−100.0% | Sold out |
| O'Shaughnessy Asset Management, LLC | 0 | $0 | 0.00% | −240−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −50−100.0% | Sold out |